Cytokine networks dysregulation during HTLV-1 infection and associated diseases

N Futsch, G Prates, R Mahieux, J Casseb, H Dutartre - Viruses, 2018 - mdpi.com
Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of a neural chronic
inflammation, called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) …

[HTML][HTML] Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia/lymphoma …

SA Ghezeldasht, A Shirdel… - Iranian journal of …, 2013 - ncbi.nlm.nih.gov
The study of tumor viruses paves the way for understanding the mechanisms of virus
pathogenesis, including those involved in establishing infection and dissemination in the …

Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein …

M Glenn, L Rainbow, F Auradé, A Davison… - Journal of …, 1999 - Am Soc Microbiol
Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV-8) is a
novel herpesvirus implicated as the causative agent of Kaposi's sarcoma (KS), primary …

HTLV, a multi organ oncovirus

S Ramezani, SA Rezaee, Z Farjami, N Ebrahimi… - Microbial …, 2022 - Elsevier
Human T lymphotropic virus (HTLV-I) is a retrovirus that has been recognized as a causative
agent of two crucidal diseases, HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis …

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy

A Pasquier, S Alais, L Roux, MI Thoulouze… - Frontiers in …, 2018 - frontiersin.org
Five to ten million individuals are infected by Human T-cell Leukemia Virus type 1 (HTLV-1).
HTLV-1 is transmitted through prolonged breast-feeding, by sexual contacts and by …

XCL1, a serum biomarker in neurological diseases; HTLV-1-associated myelopathy and multiple sclerosis

M Saeidi, Z Vahidi, MA Nahayati, MK Rezaiyan… - Microbial …, 2023 - Elsevier
The XCL1-XCR1 axis has a potential role in the recruitment of immune cells to the site of
inflammation. The present study aimed to examine the relation of XCL1 serum levels with …

[HTML][HTML] Molecular targeting for treatment of human T-lymphotropic virus type 1 infection

A Soltani, SI Hashemy, FZ Avval, A Soleimani… - Biomedicine & …, 2019 - Elsevier
Human T-cell lymphotropic virus type 1 (HTLV-1) infection is linked to adult T-cell leukemia-
lymphoma (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis …

HTLV‐1 oncovirus‐host interactions: From entry to the manifestation of associated diseases

S Ahmadi Ghezeldasht, SAA Shamsian… - Reviews in medical …, 2021 - Wiley Online Library
Human T lymphotropic virus type‐1 (HTLV‐1) is a well‐known human oncovirus, associated
with two life‐threatening diseases, adult T cell leukaemia/lymphoma (ATL) and HTLV‐1 …

[HTML][HTML] Triple therapy with prednisolone, pegylated interferon and sodium valproate improves clinical outcome and reduces human T-cell leukemia virus type 1 …

R Boostani, R Vakili, SS Hosseiny, A Shoeibi, B Fazeli… - …, 2015 - Elsevier
Considering that there is no effective treatment for human T-cell leukemia virus type 1 (HTLV-
1)-associated myelopathy/tropical spastic paraparesis, this study aimed to assess the impact …

CD80+ and CD86+B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis

SM Menezes, D Decanine, D Brassat, R Khouri… - Journal of …, 2014 - Springer
Background Human T-cell lymphotropic virus (HTLV-1) is the causative agent of the
incapacitating, neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic …